Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Bone Marrow Transplantation

Free Subscription Articles published in Bone Marrow Transplant Retrieve available abstracts of 39 articles: HTML format

Single Articles

September 2025
1. BARTHELEMY C, Jestin M, Brignier A, Parquet N, et al
   Early administration of selected CD34 peripheral blood stem cell following bone marrow transplantation to prevent graft rejection: experience in haploidentical transplant for sickle cell disease.
   Bone Marrow Transplant. 2025 Sep 12. doi: 10.1038/s41409-025-02685.
   PubMed    
   
   
   April 2025
2. GALEANO S, Bonfim C, Karduss A, Jaimovich G, et al
   Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors.
   Bone Marrow Transplant. 2025 Apr 18. doi: 10.1038/s41409-025-02600.
   PubMed     Abstract available
   
   
   
3. MICHONNEAU D, Malard F, Le Grand S, Magro L, et al
   Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy.
   Bone Marrow Transplant. 2025 Apr 1. doi: 10.1038/s41409-025-02554.
   PubMed     Abstract available
   
   
   January 2025
4. RODRIGUES AM, Fernandes JF, Gregianin L, Nichele S, et al
   Hematopoietic stem cell transplantation in inborn errors of metabolism-a retrospective analysis on behalf of the pediatric disease working party from the Brazilian Society of Bone Marrow Transplantation and Cellular Therapy.
   Bone Marrow Transplant. 2025 Jan 26. doi: 10.1038/s41409-025-02512.
   PubMed     Abstract available
   
   
   October 2024
5. GLUCKMAN E, Sureda A
   Half a century of healing: celebrating the 50th anniversary of EBMT.
   Bone Marrow Transplant. 2024;59:1341-1348.
   PubMed     Abstract available
   
   
   
6. 
   The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Patient Advocacy - Poster Session (P808-P815).
   Bone Marrow Transplant. 2024;59.
   PubMed    
   
   
   
7. 
   The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Patient Advocacy - Oral Session (O164-O169).
   Bone Marrow Transplant. 2024;59.
   PubMed    
   
   
   
8. 
   The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Statistical Symposium - Poster Session (P803-P807).
   Bone Marrow Transplant. 2024;59.
   PubMed    
   
   
   
9. 
   The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Quality Management Group - Poster Session (P783-P802).
   Bone Marrow Transplant. 2024;59.
   PubMed    
   
   
   
10. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Quality Management Group - Oral Session (O160-O163).
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
11. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Data Management Group - Poster Session (P771-P782).
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
12. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Pharmacist Committee - Poster Session (P762-P770).
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
13. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Pharmacist Committee - Oral Session (O155-O159).
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
14. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Psychiatry and Psychology Group - Poster Session (P756-P761).
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
15. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Nurses Group - Poster Sessions (NP001-NP079).
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
16. 
    The 50th Annual Meeting of the European Society for Blood and Marrow Transplantation: Nurses Group - Oral Session (NO001-NO026).
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
17. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Poster Session (P001-P755).
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
18. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Session (O009-O154).
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
19. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Award Winners (O001-O008).
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
20. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Reviewers.
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
21. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Van Bekkum Awards.
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
22. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Lectures.
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
23. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Organising committee.
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    
24. 
    The 50(th) Annual Meeting of the European Society for Blood and Marrow Transplantation: Welcome Address.
    Bone Marrow Transplant. 2024;59.
    PubMed    
    
    
    May 2024
25. SINANIDIS I, Hochman MJ, Tsai HL, Randall MP, et al
    Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide.
    Bone Marrow Transplant. 2024 May 7. doi: 10.1038/s41409-024-02299.
    PubMed    
    
    
    
26. GRIMAUD Y, Sicre de Fontbrune F, Michonneau D, Desnoyer A, et al
    How to decrease bone marrow collection volume and risk contaminations via the operating room cell concentration?
    Bone Marrow Transplant. 2024;59:711-713.
    PubMed    
    
    
    April 2024
27. FILIOGLOU D, Truscott L, Reddivalla N, Katsanis E, et al
    Outcomes of haploidentical bone marrow transplantation in infant acute leukemia: a single center experience.
    Bone Marrow Transplant. 2024 Apr 9. doi: 10.1038/s41409-024-02281.
    PubMed    
    
    
    February 2024
28. GALE RP, Lazarus HM
    Is myelo-ablative pretransplant conditioning really myelo-ablative: Implications for radiation and nuclear accidents?
    Bone Marrow Transplant. 2024;59:159-161.
    PubMed    
    
    
    December 2023
29. MEYERS G, Hamadani M, Martens M, Ali H, et al
    Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.
    Bone Marrow Transplant. 2023;58:1416-1418.
    PubMed    
    
    
    November 2023
30. CAO LQ, Huo WX, Zhang XH, Xu LP, et al
    Peripheral blood stem cell transplantation from haploidentical related donor could achieve satisfactory clinical outcomes for intermediate- or high-risk adult acute myeloid leukemia patients.
    Bone Marrow Transplant. 2023 Nov 15. doi: 10.1038/s41409-023-02117.
    PubMed     Abstract available
    
    
    
31. FUJI S, Hakoda A, Kanda J, Fukuda T, et al
    Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy.
    Bone Marrow Transplant. 2023;58:1257-1259.
    PubMed    
    
    
    October 2023
32. SHIMOMURA Y, Komukai S, Kitamura T, Sobue T, et al
    Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide.
    Bone Marrow Transplant. 2023 Oct 28. doi: 10.1038/s41409-023-02142.
    PubMed     Abstract available
    
    
    September 2023
33. HONG J, Fraebel J, Yang Y, Tkacyk E, et al
    Understanding and treatment of cutaneous graft-versus-host-disease.
    Bone Marrow Transplant. 2023 Sep 20. doi: 10.1038/s41409-023-02109.
    PubMed     Abstract available
    
    
    
34. WOREL N, Ljungman P, Verheggen ICM, Hoogenboom JD, et al
    Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Pa
    Bone Marrow Transplant. 2023 Sep 6. doi: 10.1038/s41409-023-02099.
    PubMed     Abstract available
    
    
    August 2023
35. RAGHUNANDAN S, Gorfinkel L, Bratrude B, Suessmuth Y, et al
    Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.
    Bone Marrow Transplant. 2023 Aug 14. doi: 10.1038/s41409-023-02034.
    PubMed    
    
    
    July 2023
36. XU ZL, Xu LP, Zhang YY, Cheng YF, et al
    Mixed chimaerism is associated with poorer long-term failure-free survival among aplastic anaemia patients receiving HLA-matched donor transplantation.
    Bone Marrow Transplant. 2023;58:832-834.
    PubMed    
    
    
    June 2023
37. DE WITTE MA, Mooyaart JE, Hoogenboom JD, Chabannon C, et al
    Activity of ex vivo graft and DLI Engineering within the last decade increases, a survey from the EBMT Cellular Therapy & Immunobiology Working Party.
    Bone Marrow Transplant. 2023;58:719-722.
    PubMed    
    
    
    March 2023
38. MOISEEV I, Ambron P, Badoglio M, Peczynski C, et al
    Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT.
    Bone Marrow Transplant. 2023;58:325-327.
    PubMed    
    
    
    November 2022
39. MOISEEV I, Barabanshikova M, Dotsenko A, Smirnova A, et al
    First-line steroid-free systemic treatment of acute and chronic graft-versus-host disease after novel prophylaxis regimens.
    Bone Marrow Transplant. 2022 Nov 30. doi: 10.1038/s41409-022-01879.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bone Marrow Transplantation is free of charge.